Diabetes-Related Discrimination at Workplace and by Insurances
NCT ID: NCT00661908
Last Updated: 2008-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
509 participants
OBSERVATIONAL
2004-03-31
2008-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
By distributing a self-report questionnaire to insulin-treated Type 1 and Type 2 diabetic subjects we wanted to analyse the frequency of work- and insurance-related discrimination. Furthermore we wanted to detect socio-demographic and diabetes-related factors which are associated with increased discrimination at workplace and by insurances. We hypothesized that diabetes-related discrimination at workplace and by insurances exists and that certain factors like having severe hypoglycaemic events, being type 1 diabetic or being overweight would be associated with more problems at work or with insurances.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aims of this study are to investigate the prevalence of discrimination at workplace and by insurances due to diabetes mellitus. Furthermore we want analyse if socio-demographic factors (age,gender,origin) show an impact on diabetes-related discrimination at workplace and by insurances. We hypothesize furthermore that certain diabetes-related factors like having severe hypoglycemias, being type 1 diabetic, having diabetic complications or being overweight/obese is associated with more problems at work and with insurances.
Data will be analysed by a multiple ordinal regression analysis. We will correct data for age, gender, employment status and diabetes type.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
insulin-treated diabetic subjects of North-western part of Switzerland
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Diabetes Association Basel
OTHER
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospital of Basel, Switzerland
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Piera M Nebiker, MD
Role: PRINCIPAL_INVESTIGATOR
University of Basel
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
274/03
Identifier Type: -
Identifier Source: org_study_id